Patient symptom and quality of life assessments must be inclusive and equitable
Information reported directly by patients can be invaluable for assessing the impact of disease and treatment on patients’ symptoms and quality of life -but more needs to be done to include under-ser…
Revolutionary technology has potential to help children with asthma
BHP members Birmingham Women’s and Children’s Hospitals have initiated a new study which could potentially revolutionise care for young people with asthma using artificial intelligence technology…
Experts at Birmingham Women’s and Children’s develop new test to spot rare eye cancer in unborn babies
Experts from BHP members Birmingham Women’s and Children’s Hospitals have developed a life-saving test that allows doctors to spot a rare form of eye cancer in babies in the womb.
The test, which…
New spinout Healome Therapeutics to speed development for eye therapeutics
BHP founder-member the University of Birmingham has created a new spinout, Healome Therapeutics Ltd, to commercially deploy a platform that delivers a ‘pro-healing’ microenvironment for the leading c…
Urine test for bladder cancer could replace thousands of invasive procedures each year
Birmingham researchers funded by Cancer Research UK and liquid biopsy company Nonacus have developed a new urine test for bladder cancer, which could reduce the need for invasive and time-consuming p…
Civilians and military take part in study to improve concussion prognosis
A major UK study to identify new ways to accurately predict if patients will develop long-term complications as a consequence of concussion has been launched, led by experts at BHP founder-member the…